Drug Type Mesenchymal stem cell therapy |
Synonyms CNS specific amniotic mesenchymal stem cell therapy (Amniotics) |
Target- |
Mechanism Cell replacements |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | SE | 30 Apr 2024 | |
Amyotrophic Lateral Sclerosis | Preclinical | SE | 30 Apr 2024 | |
Parkinson Disease | Preclinical | SE | 30 Apr 2024 | |
Spinal Muscular Atrophy | Discovery | SE | - |